These include alterations in β-integrin signaling, which is consistent with previous work showing reduced β-integrin on the cell surface in SORL1KO cancer cells [63], and altered interactions in ephrins/ephrin receptors, also corroborating previous work implicating SORL1 expression in ephrin signaling and synapse regulation [34]. This evidence concerns the gene SORL1 and cancer.